Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/2/13 → 03/28/20 |
Funding
- Brigham and Womens Hospital: $43,120.24
Astrazeneca: Dapagliflozin Evaluation of Cardiovascular Events (DECLARE - TIMI 58); A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3b Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of...
- Lawson, William (PI)
- Parikh, Puja (CoPI)
- Gruberg, Luis (PI)
- Jeremias, Allen (CoPI)
- Mani, Anil (CoPI)
Project: Research